Board of Directors
Jordan Green, Ph.D., John Hopkins, VasoRx Director
Dr. Green is a Professor of Biomedical Engineering, Ophthalmology, Oncology, Neurosurgery, Chemical & Biomolecular Engineering, and Materials Science & Engineering, at the Johns Hopkins University School of Medicine. He is an associate researcher of the Institute for NanoBioTechnology and co-founder and associate director of the Translational Tissue Engineering Center at JHU. Dr. Green received his B.S. in biomedical engineering and in chemical engineering from Carnegie Mellon University in 2003 and completed his Ph.D. in biological engineering from the Massachusetts Institute of Technology in 2007. Dr. Green is also a Fellow of the American Institute for Medical and Biological Engineering. He has received numerous awards including the American Institute of Chemical Engineers Allan Colburn Award, the Biomedical Engineering Society Rita Schaffer Award, the American Society for Engineering Education Curtis W. McGraw Research Award, the Presidential Early Career Award for Scientists and Engineers, and is a National Academy of Medicine Emerging Leader in Health & Medicine.
Anthony Ware, M.D., VasoRx Director
Dr. Ware served as the Senior Vice President of Product Development of Lilly Bio-Medicines at Eli Lilly and Company, where he was responsible for the clinical development and regulatory approval of new medicines in multiple therapeutic areas. His sixteen year tenure at Eli Lilly has included the clinical development, regulatory approval and launch of numerous novel therapeutics, including Taltz®, Olumiant®, Cymbalta®, Cialis®, Effient® and Trulicity®. Prior to Eli Lilly, Dr. Ware served as Professor of Medicine and Molecular Pharmacology at Albert Einstein College of Medicine in New York, where he was also Chief of Cardiology at Montefiore Medical Center. Before then, Dr. Ware was on the faculty of Harvard Medical School and also served as a senior physician and Director of the Coronary Care Unit at Beth Israel Hospital. Dr. Ware currently serves as a member of the board of directors of AnaptysBio a NASDAQ-listed biotech company. Dr. Ware received a Bachelor of Science degree from Washburn University, a Medical Degree from the University of Kansas, has served in internships at the University of Texas at Houston and Baylor College of Medicine, and is board certified both in internal medicine and cardiovascular